Epstein-Barr Virus Infections - 22 Studies Found
Recruiting |
: A Study of the Safety and Efficacy of EBV Specific T-cell Lines :
|
Completed |
: Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection : Infectious Mononucleosis : 2007-12-14 :
|
Completed |
: Modified Vaccinia Ankara (MVA) Vaccine Study :
: Drug: MVA Vaccine The starting dose will be 5 x 107 plaque forming units (pfu) given by intradermal vacc |
Completed |
: EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC) :
: 2004-03-01 :
|
Completed |
: The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis :
: |
Active, not recruiting |
: Bortezomib Plus Rituximab for EBV+ PTLD :
|
No longer available |
: Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH) :
|
Completed |
: Surveillance Study of Viral Infections Following Lung Transplantation :
|
Completed |
: Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE) :
: Biological: Multi-virus Specific T cells Subjects will rec |